Aytu Biopharma AYTU
NASDAQ AYTU
$2.07 -0.02 (-0.96%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aytu Biopharma (AYTU) Short-term Investments (2016)

Updated

Aytu Biopharma (AYTU) posted Short-term Investments of $1.27 million for fiscal Q2 2017 (quarter ended Dec 31, 2016), down 28.1% from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Short-term Investments (2016) Analysis & Trends

At the end of FY2016 (ended Jun 30, 2016), Aytu Biopharma's Short-term Investments came in at $1.04 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Aytu Biopharma 22.49 Mn -93.18 Mn 10.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 1.27 Mn
Sep 30, 2016 1.77 Mn
Jun 30, 2016 1.04 Mn
API Access

Aytu Biopharma Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=AYTU&period=max&api_key=YOUR_API_KEY